tiprankstipranks
Nuvectis Pharma reports Q3 EPS (24c), consensus (25c)
PremiumThe FlyNuvectis Pharma reports Q3 EPS (24c), consensus (25c)
2M ago
Nuvectis Pharma announces U.S. FDA granted ODD for NXP800
Premium
The Fly
Nuvectis Pharma announces U.S. FDA granted ODD for NXP800
4M ago
Nuvectis Pharma cancer treatment granted FDA orphan designation
Premium
The Fly
Nuvectis Pharma cancer treatment granted FDA orphan designation
4M ago
Nuvectis Pharma Inc trading resumes
PremiumThe FlyNuvectis Pharma Inc trading resumes
9M ago
Nuvectis Pharma Inc trading halted, volatility trading pause
Premium
The Fly
Nuvectis Pharma Inc trading halted, volatility trading pause
9M ago
Nuvectis Pharma announces preliminary data from NXP800 Phase 1b trial
Premium
The Fly
Nuvectis Pharma announces preliminary data from NXP800 Phase 1b trial
9M ago
Nuvectis Pharma announces initiation of NXP9000 Phase 1a trial
PremiumThe FlyNuvectis Pharma announces initiation of NXP9000 Phase 1a trial
1y ago
Nuvectis Pharma announces ODD granted by FDA to NXP800
Premium
The Fly
Nuvectis Pharma announces ODD granted by FDA to NXP800
1y ago
Nuvectis granted orphan status for cholangiocarcinoma treatment
Premium
The Fly
Nuvectis granted orphan status for cholangiocarcinoma treatment
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100